216 related articles for article (PubMed ID: 23772156)
21. Comparison of abdominal bloating severity between Irritable Bowel Syndrome patients with high and low levels of breath hydrogen excretion in a lactulose breath test.
Lasa J; Peralta D; Dima G; Novillo A; Besasso H; Soifer L
Rev Gastroenterol Mex; 2012; 77(2):53-7. PubMed ID: 22658548
[TBL] [Abstract][Full Text] [Related]
22. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
Rana SV; Sharma S; Kaur J; Sinha SK; Singh K
Digestion; 2012; 85(3):243-7. PubMed ID: 22472730
[TBL] [Abstract][Full Text] [Related]
23. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome.
Ong DK; Mitchell SB; Barrett JS; Shepherd SJ; Irving PM; Biesiekierski JR; Smith S; Gibson PR; Muir JG
J Gastroenterol Hepatol; 2010 Aug; 25(8):1366-73. PubMed ID: 20659225
[TBL] [Abstract][Full Text] [Related]
24. Effect of Bifidobacterium infantis 35624 (Align) on the Lactulose Breath Test for Small Intestinal Bacterial Overgrowth.
Kumar K; Saadi M; Ramsey FV; Schey R; Parkman HP
Dig Dis Sci; 2018 Apr; 63(4):989-995. PubMed ID: 29397491
[TBL] [Abstract][Full Text] [Related]
25. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?
Reddymasu SC; Sostarich S; McCallum RW
BMC Gastroenterol; 2010 Feb; 10():23. PubMed ID: 20175924
[TBL] [Abstract][Full Text] [Related]
26. A combined nutrient and lactulose challenge test allows symptom-based clustering of patients with irritable bowel syndrome.
Le Nevé B; Posserud I; Böhn L; Guyonnet D; Rondeau P; Tillisch K; Naliboff B; Mayer EA; Simrén M
Am J Gastroenterol; 2013 May; 108(5):786-95. PubMed ID: 23588235
[TBL] [Abstract][Full Text] [Related]
27. Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study.
Pimentel M; Chatterjee S; Chow EJ; Park S; Kong Y
Dig Dis Sci; 2006 Aug; 51(8):1297-301. PubMed ID: 16832617
[TBL] [Abstract][Full Text] [Related]
28. Breath hydrogen and methane are associated with intestinal symptoms in patients with chronic pancreatitis.
Kim DB; Paik CN; Sung HJ; Chung WC; Lee KM; Yang JM; Choi MG
Pancreatology; 2015; 15(5):514-518. PubMed ID: 26278025
[TBL] [Abstract][Full Text] [Related]
29. Incidence of predominant methanogenic flora in irritable bowel syndrome patients and apparently healthy controls from North India.
Rana SV; Sharma S; Sinha SK; Kaur H; Sikander A; Singh K
Dig Dis Sci; 2009 Jan; 54(1):132-5. PubMed ID: 18493854
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study.
Scarpellini E; Giorgio V; Gabrielli M; Lauritano EC; Pantanella A; Fundarò C; Gasbarrini A
J Pediatr; 2009 Sep; 155(3):416-20. PubMed ID: 19535093
[TBL] [Abstract][Full Text] [Related]
31. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.
Tuteja AK; Talley NJ; Stoddard GJ; Verne GN
Dig Dis Sci; 2019 Mar; 64(3):838-845. PubMed ID: 30370492
[TBL] [Abstract][Full Text] [Related]
32. The clinical value of breath ammonia determination in patients with irritable bowel syndrome.
Chojnacki C; Błońska A; Mędrek-Socha M; Chojnacki M; Konrad P
Pol Merkur Lekarski; 2022 Dec; 50(300):360-363. PubMed ID: 36645681
[TBL] [Abstract][Full Text] [Related]
33. Effect of predominant methanogenic flora on outcome of lactose hydrogen breath test in controls and irritable bowel syndrome patients of north India.
Rana SV; Sinha SK; Sharma S; Kaur H; Bhasin DK; Singh K
Dig Dis Sci; 2009 Jul; 54(7):1550-4. PubMed ID: 19003533
[TBL] [Abstract][Full Text] [Related]
34. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls.
Walters B; Vanner SJ
Am J Gastroenterol; 2005 Jul; 100(7):1566-70. PubMed ID: 15984983
[TBL] [Abstract][Full Text] [Related]
35. Functional Dyspepsia and Severity of Psychologic Symptoms Associate With Postprandial Symptoms in Patients With Irritable Bowel Syndrome.
Pohl D; Van Oudenhove L; Törnblom H; Le Nevé B; Tack J; Simrén M
Clin Gastroenterol Hepatol; 2018 Nov; 16(11):1745-1753.e1. PubMed ID: 29702295
[TBL] [Abstract][Full Text] [Related]
36. The relationship between small intestinal bacterial overgrowth and irritable bowel syndrome.
Ding XW; Liu YX; Fang XC; Liu K; Wei YY; Shan MH
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5191-5196. PubMed ID: 29228433
[TBL] [Abstract][Full Text] [Related]
37. Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea.
Rezaie A; Heimanson Z; McCallum R; Pimentel M
Am J Gastroenterol; 2019 Dec; 114(12):1886-1893. PubMed ID: 31688023
[TBL] [Abstract][Full Text] [Related]
38. Factor analysis demonstrates a symptom cluster related to methane and non-methane production in irritable bowel syndrome.
Makhani M; Yang J; Mirocha J; Low K; Pimentel M
J Clin Gastroenterol; 2011 Jan; 45(1):40-4. PubMed ID: 20871407
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of functional gastrointestinal disorders from healthy volunteers by lactulose hydrogen breath test and test meal.
Schindler V; Giezendanner S; Bütikofer S; Murray F; Runggaldier D; Schnurre L; Zweig A; Fried M; Pohl D
J Gastroenterol Hepatol; 2019 May; 34(5):843-851. PubMed ID: 30562837
[TBL] [Abstract][Full Text] [Related]
40. Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome.
Scarpellini E; Giorgio V; Gabrielli M; Filoni S; Vitale G; Tortora A; Ojetti V; Gigante G; Fundarò C; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1314-20. PubMed ID: 23740443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
